| WKN: | 928619 |
| ISIN: | CH0013841017 |
| Land: | Schweiz |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Chemie |
Weshalb die Lonza Group-Aktie
ein AAA-Rating hat,
erfahren Sie im Performance-Check
vom 27. Oktober 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2013 | 37,89 | 63,94 | 68,78% |
| 2 | 2020 | 324,92 | 525,91 | 61,86% |
| 3 | 2015 | 86,44 | 138,93 | 60,73% |
| 4 | 2024 | 380,42 | 570,96 | 50,09% |
| 5 | 2017 | 152,34 | 225,02 | 47,71% |
| 6 | 2019 | 226,02 | 324,92 | 43,76% |
| 7 | 2021 | 525,91 | 735,03 | 39,76% |
| 8 | 2014 | 63,94 | 86,44 | 35,18% |
| 9 | 2007 | 60,60 | 76,89 | 26,89% |
| 10 | 2006 | 47,90 | 60,60 | 26,50% |
| 11 | 2005 | 38,36 | 47,90 | 24,89% |
| 12 | 2010 | 45,59 | 55,52 | 21,78% |
| 13 | 2001 | 57,35 | 67,98 | 18,54% |
| 14 | 2025 | 570,96 | 627,80 | 9,96% |
| 15 | 2016 | 138,93 | 152,34 | 9,65% |
| 16 | 2000 | 55,88 | 57,35 | 2,64% |
| 17 | 2018 | 225,02 | 226,02 | 0,44% |
| 18 | 2004 | 42,22 | 38,36 | -9,15% |
| 19 | 2012 | 42,35 | 37,89 | -10,55% |
| 20 | 2023 | 458,87 | 380,42 | -17,10% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 735,03 | 458,87 | -37,57% |
| 2 | 2009 | 61,07 | 45,59 | -25,35% |
| 3 | 2011 | 55,52 | 42,35 | -23,72% |
| 4 | 2003 | 53,63 | 42,22 | -21,27% |
| 5 | 2002 | 67,98 | 53,63 | -21,12% |
| 6 | 2008 | 76,89 | 61,07 | -20,58% |
| 7 | 2023 | 458,87 | 380,42 | -17,10% |
| 8 | 2012 | 42,35 | 37,89 | -10,55% |
| 9 | 2004 | 42,22 | 38,36 | -9,15% |
| 10 | 2018 | 225,02 | 226,02 | 0,44% |
| 11 | 2000 | 55,88 | 57,35 | 2,64% |
| 12 | 2016 | 138,93 | 152,34 | 9,65% |
| 13 | 2025 | 570,96 | 627,80 | 9,96% |
| 14 | 2001 | 57,35 | 67,98 | 18,54% |
| 15 | 2010 | 45,59 | 55,52 | 21,78% |
| 16 | 2005 | 38,36 | 47,90 | 24,89% |
| 17 | 2006 | 47,90 | 60,60 | 26,50% |
| 18 | 2007 | 60,60 | 76,89 | 26,89% |
| 19 | 2014 | 63,94 | 86,44 | 35,18% |
| 20 | 2021 | 525,91 | 735,03 | 39,76% |